Clark Estates Inc holds a focused book of 90 stocks worth $433.7M as of Q2 2026 (disclosed Aug 5, 2026, a ~36-day 13F lag). This quarter they opened Vanguard Ftse Developed ETF and trimmed Eucldean Fundmntl Val ETF Ec. Their largest long position is Eucldean Fundmntl Val ETF Ec at 15% of the equity book.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
77% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Clark Estates Inc
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BANK OF AMERICA CORP /DE/ | 80 / 80 | $74.8B |
| UBS Group AG | 80 / 80 | $28.2B |
| BlackRock, Inc. | 79 / 80 | $524.3B |
| FMR LLC | 79 / 80 | $120.3B |
| MORGAN STANLEY | 79 / 80 | $116.8B |
| JPMORGAN CHASE & CO | 79 / 80 | $116.6B |
| GOLDMAN SACHS GROUP INC | 79 / 80 | $50.6B |
| ROYAL BANK OF CANADA | 79 / 80 | $33.8B |
Ranked by how many of Clark Estates Inc's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Ea Series Trust EUCL FUN VAL ETF | $66.7M | 1.72M | 15.4% | ▼−19% Reduced · −397K sh | |
| 2 | Vanguard Tax-Managed FDS VAN FTSE DEV MKT | $26.4M | 371.1K | 6.1% | ▲New New position | |
| 3 | Unilever PLC SPON ADR NEW | $22.2M | 370.0K | 5.1% | ▲+21% Added · +65K sh | |
| 4 | Disney Walt Co COM | $19.3M | 200.0K | 4.4% | —Held | |
| 5 | Amrize Ltd SHS | $17.3M | 325.0K | 4.0% | ▲+14% Added · +40K sh | |
| 6 | Sony Group Corp SPONSORED ADR | $16.5M | 825.0K | 3.8% | ▲+19% Added · +133K sh | |
| 7 | Haleon PLC SPON ADS | $15.9M | 1.70M | 3.7% | ▲+21% Added · +300K sh | |
| 8 | Solventum Corp COM SHS | $15.4M | 200.0K | 3.6% | ▼−31% Reduced · −90K sh | |
| 9 | Bausch Plus Lomb Corp COMMON SHARES | $14.6M | 881.0K | 3.4% | ▲+6.8% Added · +56K sh | |
| 10 | Warner Music Group Corp COM CL A | $14.5M | 535.0K | 3.3% | ▼−18% Reduced · −115K sh | |
| 11 | Schein Henry Inc COM | $11.3M | 135.0K | 2.6% | ▲17× Added · +127K sh | |
| 12 | Iqvia Hldgs Inc COM | $10.1M | 52.2K | 2.3% | ▼−45% Reduced · −43K sh | |
| 13 | Shattuck Labs Inc COM | $9.9M | 1.43M | 2.3% | ▼−3.1% Reduced · −45K sh | |
| 14 | Medtronic PLC SHS | $7.0M | 90.0K | 1.6% | ▼−42% Reduced · −65K sh | |
| 15 | Wiley John & Sons Inc CL A | $4.6M | 94.4K | 1.1% | ▲+41% Added · +27K sh | |
| 16 | 3D Sys Corp Del COM NEW | $4.3M | 1.42M | 1.0% | —Held | |
| 17 | Smith & Nephew PLC SPDN ADR NEW | $4.1M | 143.5K | 1.0% | ▼−35% Reduced · −77K sh | |
| 18 | Pediatrix Medical Group Inc COM | $3.9M | 153.0K | 0.9% | ▲+19% Added · +24K sh | |
| 19 | Indivior Pharmaceuticals Inc COM | $3.8M | 92.3K | 0.9% | —Held | |
| 20 | Catalyst Pharmaceuticals Inc COM | $3.6M | 113.9K | 0.8% | —Held | |
| 21 | Halozyme Therapeutics Inc COM | $3.5M | 44.9K | 0.8% | —Held | |
| 22 | Altria Group Inc COM | $3.5M | 48.6K | 0.8% | —Held | |
| 23 | Crocs Inc COM | $3.5M | 28.9K | 0.8% | —Held | |
| 24 | Best Buy Inc COM | $3.3M | 43.7K | 0.8% | ▲New New position | |
| 25 | Biogen Inc COM | $3.3M | 15.3K | 0.8% | —Held | |
| 26 | Gilead Sciences Inc COM | $3.3M | 26.0K | 0.8% | —Held | |
| 27 | Ziff Davis Inc COM | $3.3M | 62.4K | 0.8% | ▼−10% Reduced · −7K sh | |
| 28 | Strategic Ed Inc COM | $3.2M | 42.3K | 0.7% | ▲+53% Added · +15K sh | |
| 29 | Wex Inc COM | $3.1M | 21.8K | 0.7% | ▲+44% Added · +7K sh | |
| 30 | Teradata Corp Del COM | $3.0M | 87.6K | 0.7% | ▼−10% Reduced · −10K sh | |
| 31 | World Kinect Corporation COM | $3.0M | 91.6K | 0.7% | —Held | |
| 32 | Harmony Biosciences Hldgs In COM | $3.0M | 81.3K | 0.7% | —Held | |
| 33 | Frontdoor Inc COM | $2.9M | 38.0K | 0.7% | —Held | |
| 34 | Smith A O Corp COM | $2.9M | 46.0K | 0.7% | ▲New New position | |
| 35 | Dorman Prods Inc COM | $2.9M | 21.0K | 0.7% | —Held | |
| 36 | Match Group Inc New COM | $2.8M | 74.8K | 0.7% | —Held | |
| 37 | Incyte Corp COM | $2.8M | 25.0K | 0.7% | —Held | |
| 38 | Expedia Group Inc COM NEW | $2.8M | 11.0K | 0.6% | ▼−0.9% Reduced · −100 sh | |
| 39 | Addus Homecare Corp COM | $2.8M | 28.0K | 0.6% | ▲New New position | |
| 40 | Viatris Inc COM | $2.7M | 171.6K | 0.6% | —Held | |
| 41 | Gentex Corp COM | $2.7M | 105.0K | 0.6% | ▲New New position | |
| 42 | Trinet Group Inc COM | $2.6M | 52.5K | 0.6% | ▲New New position | |
| 43 | CDW Corp COM | $2.6M | 18.3K | 0.6% | —Held | |
| 44 | Onespan Inc COM | $2.5M | 177.0K | 0.6% | —Held | |
| 45 | Bristol-Myers Squibb Co COM | $2.5M | 43.0K | 0.6% | —Held | |
| 46 | Option Care Health Inc COM NEW | $2.5M | 118.0K | 0.6% | ▲New New position | |
| 47 | Maximus Inc COM | $2.5M | 45.7K | 0.6% | ▲+68% Added · +19K sh | |
| 48 | Korn Ferry COM NEW | $2.5M | 36.8K | 0.6% | —Held | |
| 49 | Upbound Group Inc COM | $2.4M | 113.0K | 0.6% | —Held | |
| 50 | KBR Inc COM | $2.4M | 69.2K | 0.6% | ▲+32% Added · +17K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1056466/holdings"
Use Arkolith to show CLARK ESTATES INC/NY's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.